Kumudhavalli Kavanoor Sridhar

Dr. Kumudhavalli Kavanoor Sridhar

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
RBRuchika Bagga
Ruchika Bagga
KSKumudhavalli Kavanoor Sridhar
Kumudhavalli Kavanoor Sridhar
Invasive fungal diseases (IFDs) represent an escalating global health threat, compounded by the rapid emergence of antifungal resistance (AFR). This review synthesizes the contemporary landscape of AFR from clinical and microbiological perspectives, providing actionable insights for clinical practitioners. We examine the epidemiology of critical pathogens, including Candidozyma auris, clonal Candida parapsilosis, azole-resistant Aspergillus fumigatus, and dissect the underlying molecular mechanisms, from genetic mutations in ERG11 and cyp51A to novel emerging epigenetic and adaptive strategies. We critically appraise the diagnostic gap between phenotypic testing and clinical urgency, highlighting the role of rapid molecular assays and next-generation sequencing. Finally, we evaluate evidence-based therapeutic strategies, including the integration of novel agents such as rezafungin, ibrexafungerp, olorofim, and fosmanogepix), while emphasizing the imperative of antifungal stewardship, infection prevention and control in mitigating resistance, and “One-Health” interventions.

4 April 2022 in Cureus
Verified
Journal Article
Open access
ATAbdul Subhan Talpur
Abdul Subhan Talpur
KSKumudhavalli Kavanoor Sridhar
Kumudhavalli Kavanoor Sridhar
KSKhadeja Shabbir
Khadeja Shabbir
EAEsinkumo E Amba-Ambaiowei
Esinkumo E Amba-Ambaiowei
RHRasha M. Hasan
Rasha M. Hasan
FHFarukhzad Hafizyar
Farukhzad Hafizyar
The present study aimed to evaluate the proportion of restrictive pulmonary disease in individuals with diabetes mellitus type II patients. A cross-sectional study was performed at Liaquat University of Medical & Health Sciences between May 2020 and June 2021. All individuals aged between 40 and 65 years, irrespective of gender were included in the study. While those individuals with known obstructive lung diseases, blood disorders, or malignancy were excluded. Spirometry, total lung capacity (TLC), and carbon monoxide diffusing capacity (DLCO) measurements were conducted to obtain a pattern of restrictive disease in patients. Patients were divided into three main groups; i) prediabetes, ii) newly diagnosed cases of diabetes, iii) longstanding diabetes mellitus type II, and iv) control group. The parameters like the patients’ age, sex, medication, history of smoking, and cardiac diseases, among other demographics were recorded. The data collected was recorded on a predesigned proforma. The majority of the newly diagnosed cases, as well as long-standing diseases, were elderly males (p=0.014 and p<0.0001). Dyspnea was significantly correlated with longstanding diabetes mellitus type II as indicated by a higher mean score of 0.65 ± 0.10 (p=0.006). Smoking did not significantly correlate with diabetes mellitus type II. In patients with longstanding diabetes, 27 (14.4%) had a modified Medical Research Council (mMRC) score of greater than two while none of the controls had severe breathlessness. Reduced forced vital capacity (FVC) was detected in 16.0% of patients with longstanding diabetes and 12.8% in patients with newly diagnosed disease. Similar results were obtained for total lung capacity (TLC) and diffusing capacity (DLCO) (p=0.003 and p=0.02). Diabetes mellitus type II is significantly associated with restrictive lung disease in patients as indicated by a high number of patients with longstanding diabetes in our study who were found to have restrictive lung disease and severe dyspnea. Screening for lung dysfunction could aid in optimum management of this debilitating disease.

30 September 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
KSKumudhavalli Kavanoor Sridhar
Kumudhavalli Kavanoor Sridhar
FBFahad Buskandar
Fahad Buskandar
MDManreet Dhaliwal
Manreet Dhaliwal
GCGordane V. Calloo
Gordane V. Calloo
ABAndrea K Boggild
Andrea K Boggild
Dengue and malaria are common vector-borne tropical diseases and are associated with high morbidity and mortality. Co-infection of dengue and malaria is underestimated due to parsimonious diagnostic approaches once the diagnosis of either is made, particularly using point-of-care assays, such as rapid diagnostic tests (RDTs). We present a case of dengue and Plasmodium vivax co-infection in a returned traveler from an endemic region, in whom the epidemiology and clinical course are highly suggestive of dengue triggering a P. vivax relapse. The literature on the co-occurrence of dengue and malaria in travelers is reviewed, as is the state of knowledge surrounding dengue as a precipitant to relapsing malaria.

Verified
Journal Article
Open access
PDF file
TSTeslin Sandstrom
Teslin Sandstrom
KSKumudhavalli Kavanoor Sridhar
Kumudhavalli Kavanoor Sridhar
JJJudith Joshi
Judith Joshi
AAAli Aunas
Ali Aunas
SHSheliza Halani
Sheliza Halani
ABAndrea K Boggild
Andrea K Boggild
The causative agent of Lyme disease, Borrelia burgdorferi, is endemic to Canada, the northeastern United States, northern California, and temperate European regions. It is rarely associated with a travel-related exposure. In this report, we describe a resident of southern Ontario, Canada who developed rash, fever, and cranial nerve VII and XII palsies following a 12 day trip to Ecuador and the Galapagos islands approximately four weeks prior to referral to our center. Comprehensive microbiological work-up was notable for reactive Borrelia burgdorferi serology by modified two-tier testing (MTTT), confirming a diagnosis of Lyme disease. This case highlights important teaching points, including the classic clinical presentation of acute Lyme disease with compatible exposure pre-travel in a Lyme-endemic region of Ontario, initial manifestations during travel following acquisition of arthropod bites in Ecuador, and more severe manifestations post-travel. Given the travel history to a South American country in which Lyme disease is exceedingly uncommon, consideration of infections acquired in Ecuador necessitated a broad differential diagnosis and more comprehensive microbiological testing than would have been required in the absence of tropical travel. Additionally, cranial nerve XII involvement is an uncommon feature of Lyme neuroborreliosis, and therefore warranted consideration of an alternative, non-infectious etiology such as stroke or a mass lesion, both of which were excluded in this patient through neuroimaging.

15 January 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
RBRuchika Bagga
Ruchika Bagga
DADelport Johan Andries
Delport Johan Andries
AKAlice Kanyua
Alice Kanyua
KSKumudhavalli Kavanoor Sridhar
Kumudhavalli Kavanoor Sridhar
Vancomycin-resistant Enterococci (VRE) are established nosocomial pathogens; however, vancomycin-dependent Enterococci (VDE) represent a rare and underrecognized phenomenon. These organisms paradoxically require vancomycin for growth due to mutations in cell wall precursor synthesis. Limited awareness and significant diagnostic challenges associated with VDE can lead to delayed recognition and treatment failure. We report a case of vancomycin-dependent Enterococcus faecium isolated from a liver transplant recipient receiving oral vancomycin prophylaxis for recurrent Clostridioides difficile infection. The isolate failed to grow on standard media but exhibited robust growth on vancomycin-supplemented agar, confirmed by vancomycin disc diffusion testing and PCR detection of the vanB gene. Additionally, we reviewed four further VDE cases identified over a two-year period in our tertiary care microbiology laboratory. All patients originated from complex care settings, had significant comorbidities, and had received prolonged glycopeptide therapy. We summarize the clinical features, diagnostic findings, and microbiological challenges encountered across this case series. This series documents the first reported Canadian case of VDE and highlights the critical need for clinical vigilance and diagnostic suspicion in high-risk patients with prior enterococcal colonization and ongoing glycopeptide exposure. Laboratory findings such as failure to grow on blood agar coupled with growth around vancomycin discs should prompt specific evaluation for VDE. Our findings reinforce the necessity for targeted antimicrobial stewardship and infection prevention strategies and underscore the remarkable evolutionary adaptability of Enterococci under sustained antimicrobial pressure.

21 October 2026 in ASM Case Reports
Verified
Journal Article
Open access
KSKumudhavalli Kavanoor Sridhar
Kumudhavalli Kavanoor Sridhar
ACAaron Campigotto
Aaron Campigotto
WGWayne L. Gold
Wayne L. Gold
Background: Tinea incognito is a dermatophyte infection that loses its classic, pathognomonic diagnostic morphology due to the use of topical corticosteroids or systemic immunosuppression. This morphologic distortion frequently leads to diagnostic delays, inappropriate treatment escalation, and prolonged patient distress. Case Summary: A woman in her late 60s presented with a 10-month history of a worsening, intensely pruritic, and painful circular erythematous plaque on her right leg following a minor environmental skin abrasion. The lesion was initially diagnosed to be a bacterial infection with administration of antibiotic therapy. She was subsequently treated with three increasingly potent topical corticosteroids (mometasone furoate, fluocinonide, and clobetasol propionate), which caused paradoxical worsening. While standard fungal cultures from an incisional biopsy yielded no growth, histopathology via Gomori methenamine silver staining revealed deep fungal elements. A panfungal polymerase chain reaction (PCR) assay amplifying the internal transcribed spacer 2 region, followed by Nanopore DNA sequencing and comparison against a curated reference database, identified Trichophyton mentagrophytes complex; species-level resolution was not achievable by this method. The patient was successfully cured with a 12-week course of systemic antifungal therapy, resulting in complete clinical resolution. Conclusion: This case highlights tinea incognito as a significant diagnostic challenge. When inflammatory skin lesions paradoxically expand with topical steroid therapy, clinicians must maintain a high index of suspicion for a fungal etiology. Because conventional fungal cultures are frequently negative in this context, molecular diagnostics are valuable; dermatophyte-targeted assays applied to skin specimens are the preferred first-line molecular approach, with panfungal PCR/sequencing on tissue reserved for histology-positive, culture-negative cases.